Clinical trials
Coronary Artery Disease trials in Russia with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Meshalkin Research Institute of Pathology of Circulation | 8 |
| National Research Center of Surgery, Russia | 2 |
| AtheroNova Inc. | 1 |
| Biotronik Russia | 1 |
| Central Clinical Hospital of the Russian Academy of Sciences | 1 |
| Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | 1 |
| Institute for Atherosclerosis Research, Russia | 1 |
| Research Institute for Complex Problems of Cardiovascular Diseases, Russia | 1 |
| The Orenburg Regional Clinical Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 17 |
| Myocardial Ischemia | 4 |
| Cardiovascular Diseases | 3 |
| Atherosclerosis | 2 |
| Atrial Fibrillation | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Angina Pectoris | 1 |
| Angina, Stable | 1 |
| Arrhythmias, Cardiac | 1 |
| Coronary Disease | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.